These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36605904)

  • 1. All-cause admissions following a first ever exacerbation-related hospitalisation in COPD.
    Waeijen-Smit K; Jacobsen PA; Houben-Wilke S; Simons SO; Franssen FME; Spruit MA; Pedersen CT; Kragholm KH; Weinreich UM
    ERJ Open Res; 2023 Jan; 9(1):. PubMed ID: 36605904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.
    Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and Risk of Mortality in Patients Hospitalised Due to a First Severe COPD Exacerbation.
    Janson C; Nwaru BI; Wiklund F; Telg G; Ekström M
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2673-2682. PubMed ID: 33149565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
    Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
    Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of a preventive program and assisted hospital discharge for COPD exacerbation. A feasibility study].
    Pascual-Pape T; Badia JR; Marrades RM; Hernández C; Ballester E; Fornas C; Fernández A; Montserrat JM
    Med Clin (Barc); 2003 Mar; 120(11):408-11. PubMed ID: 12681217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the COPD Assessment Test respiratory item score on the decision to hospitalize patients with disease exacerbation in a hospital emergency department.
    Pulido Herrero E; Villanueva Etxebarria A; Aramburu Ojembarrena A; Piñera Salmerón P; Quintana López JM; Esteban González C; Gallardo Rebollal MS; Amigo Angulo JM; Urrutikoetxea Etxebarria S; Ibarrola Luengas I; Armentia Bardeci JM; García Gutiérrez S
    Emergencias; 2022 Apr; 34(2):95-102. PubMed ID: 35275459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of chronic obstructive pulmonary disease in patients admitted to a tertiary care centre for exacerbation of their disease.
    Dault R; Dubé AI; Blais L; Boileau R; Larrivée P; Dumas ME; Beauchesne MF
    Can J Hosp Pharm; 2012 Sep; 65(5):373-9. PubMed ID: 23129866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Appropriate Pharmacotherapy Management of COPD Exacerbations and Impact on 6-Month Readmission.
    Tran M; Xiang P; Rascati KL; Stock EM; Godley PJ; Coleman A; Bogart MR; Stanford RH
    J Manag Care Spec Pharm; 2016 Oct; 22(10):1186-93. PubMed ID: 27668567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Patient Profiles with High Risk of Hospital Re-Admissions for Acute COPD Exacerbations (AECOPD) in France Using a Machine Learning Model.
    Cavailles A; Melloni B; Motola S; Dayde F; Laurent M; Le Lay K; Caumette D; Luciani L; Lleu PL; Berthon G; Flament T
    Int J Chron Obstruct Pulmon Dis; 2020; 15():949-962. PubMed ID: 32431495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk patients following hospitalisation for an acute exacerbation of COPD.
    Piquet J; Chavaillon JM; David P; Martin F; Blanchon F; Roche N;
    Eur Respir J; 2013 Oct; 42(4):946-55. PubMed ID: 23349446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease.
    Seneff MG; Wagner DP; Wagner RP; Zimmerman JE; Knaus WA
    JAMA; 1995 Dec; 274(23):1852-7. PubMed ID: 7500534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of consecutive ambient air pollution on the hospital admission from chronic obstructive pulmonary disease in the Chengdu region, China.
    Zhang Y; Wang Z; Cao Y; Zhang L; Wang G; Dong F; Deng R; Guo B; Zeng L; Wang P; Dai R; Ran Y; Lyu W; Miao P; Su S
    Air Qual Atmos Health; 2021; 14(7):1049-1061. PubMed ID: 33758631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tele health care on exacerbations and hospital admissions in patients with chronic obstructive pulmonary disease: a randomized clinical trial.
    Ringbæk T; Green A; Laursen LC; Frausing E; Brøndum E; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1801-8. PubMed ID: 26366072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality.
    Suissa S; Dell'Aniello S; Ernst P
    Thorax; 2012 Nov; 67(11):957-63. PubMed ID: 22684094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self management for patients with chronic obstructive pulmonary disease.
    Zwerink M; Brusse-Keizer M; van der Valk PD; Zielhuis GA; Monninkhof EM; van der Palen J; Frith PA; Effing T
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD002990. PubMed ID: 24665053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease.
    Slade D; Ray R; Moretz C; Germain G; Laliberté F; Shen Q; Duh MS; MacKnight SD; Hahn B
    Pulm Ther; 2021 Jun; 7(1):203-219. PubMed ID: 33728597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospitalisation for COPD in Puglia: the role of hospital discharge database to estimate prevalence and incidence.
    Trerotoli P; Bartolomeo N; Moretti AM; Serio G
    Monaldi Arch Chest Dis; 2008 Sep; 69(3):94-106. PubMed ID: 19065843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Admission for COPD Exacerbation Is Associated with the Clinical Diagnosis of Pulmonary Hypertension: Results from a Retrospective Longitudinal Study of a Veteran Population.
    Medrek SK; Sharafkhaneh A; Spiegelman AM; Kak A; Pandit LM
    COPD; 2017 Oct; 14(5):484-489. PubMed ID: 28715281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.